China-focused private equity fund manager Hillhouse Capital, CPE, Lake Bleu Capital, Gamnat, China Reform Conson Soochow Overseas Fund I, Gortune Artemis Limited, and 3H Health Investment Fund have invested USD130m in MicroPort CardioFlow Medtech, a subsidiary of Hong Kong-listed medical device developer MicroPort Scientific Corporation, for a combined 10.83% stake in the company. Read more